Hospital-at-home inpatient care is no worse than its traditional counterpart at facilitating good clinical outcomes for comparable overall costs. In fact “HaH” is sometimes considerably better on both those scores.
When heart patients require aortic valve replacement, would they be a better fit for TAVR or SAVR? Such decisions are not made lightly, clinicians emphasized in a new joint statement.
“Dr. Matsumoto is a trusted physician leader with a long record of service to the college and a clear commitment to quality, safety and patient-centered care,” ACR CEO Dana H. Smetherman, MD, said May 4.
New findings support the routine use of deep learning-based risk assessments, as this method can decrease subjectivity, reduce unnecessary imaging and improve diagnostic accuracy.
Becoming a father seems to make a man less likely to die young. What’s more, when a father passes away within the first five years of his child’s life, the cause is usually non-natural and thus preventable.
Legal and compliance teams have to serve as sentinels sizing up potential legal exposure points without turning into needlers who only slow down clinical innovation.
The agency said it is seeking to exclude semaglutide, tirzepatide and liraglutide from the 503B program based on a lack of clinical evidence. Unless there’s a shortage, the pharmaceuticals would be barred from being compounded by third-parties for the purpose of treating diabetes or obesity. The FDA is seeking public comment on the proposal.
Hospital-at-home inpatient care is no worse than its traditional counterpart at facilitating good clinical outcomes for comparable overall costs. In fact “HaH” is sometimes considerably better on both those scores.
